According to Novartis, Kesimpta is the first targeted B cell ... The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy.

Novartis revealed this morning that it has ... as well as multiple sclerosis therapy Kesimpta (ofatumumab), which saw sales double to $384 million. Prostate cancer radioligand therapy Pluvicto ...

Kisqali, Pluvicto Drive Novartis (NVS) Amid Competition Per the Zacks analyst, drugs like Entresto, Kesimpta, Pluvicto ... significant exposure to commercial loans, and deteriorating asset quality ...

Hidradenitis suppurativa (HS) is a relatively common skin disease, affecting as many as one percent of people worldwide. But ...

Products like Kesimpta, Kisqali, and Cosentyx have been key contributors to this growth. However, Goldman Sachs (NYSE:GS) has adjusted its stance on Novartis, downgrading the stock from Buy to Neutral ...

Ranked by Square feet of industrial space owned in Atlanta Ranked by Square feet developed, 2023-present The acquisition of Roswell Village in Roswell, GA, marks a significant milestone on RPT’s ...

Showcase your company news with guaranteed exposure both in print and online Get your event in front of thousands of influential leaders in the Cincinnati community ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Plane is Airworthy and ready to fly! Airplane can be Delivered ‘As Is Where Is’ for $1.875M (USD) or Delivered with Fresh C-Check for $2.575M (USD). Landing Gear are good until Feb 2021, but can be ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,604.88 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

Bremen (Novartis Pharma GmbH) Oct 18, 2024 Process Expert (m/f/d) – Part-time (50%) Regulär, Part time Innovative Medicines Austria Schaftenau Oct 18, 2024 Medical Scientific Liaison Manager, ...